La vendita allo scoperto per Evonik Indus dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Evonik Indus. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Evonik Indus (OTC:EVKIY) Azioni, Report sulle vendite allo scoperto

Evonik Industries AG is a German chemical company offering a mix of specialty and commodity chemical products. The company engages in the development, construction, distribution, and trade of scientific equipment, chemicals, and accessories for use in the fields of life sciences and biotechnology. The company is organized into four segments: Specialty Additives, Smart Materials, Nutrition & Care, and Technology & Infrastructure. Its geographic segments include Europe, Middle East & Africa; North America; Central & South America; and Asia-Pacific.

EVONIK INDS AG UNSP/ADR by Evonik Industries AG

Evonik Industries AG

<p><a href="https://www.ft.com/content/ca3837bb-34e3-4e15-b4e6-f4c927a3af5a  ft.com">https://www.ft.com/content/ca3837bb-34e3-4e15-b4e6-f4c927a3af5a &nbsp;ft.com</a></p>


News

General

'UK closes in on US trade pact with lower tariff quotas for cars and steel'- Financial Times

<p>Alto Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTO#NASDAQ">ALTO</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-05-07. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Alto Ingredients will report an <strong>earnings per share</strong> (EPS) of $-0.20.</p>
<p>Investors in Alto Ingredients are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS missed by $0.05 in the last quarter, leading to a 6.8% increase in the share price on the following day.</p>
<p>Here's a look at Alto Ingredients's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.11</td>
<td>0.03</td>
<td>-0.10</td>
<td>-0.14</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.16</td>
<td>-0.04</td>
<td>-0.05</td>
<td>-0.17</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>7.000000000000001%</td>
<td>-38.0%</td>
<td>6.0%</td>
<td>-10.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554793_0.png" alt="eps graph" /></p>
<h3>Market Performance of Alto Ingredients's Stock</h3>
<p>Shares of Alto Ingredients were trading at $0.88 as of May 05. Over the last 52-week period, shares are down 51.04%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analyst Insights on Alto Ingredients</h3>
<p>For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Alto Ingredients.</p>
<p>The consensus rating for Alto Ingredients is Buy, based on 1 analyst ratings. With an average one-year price target of $5.5, there's a potential 525.0% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Arq, Rayonier Adv Materials and Aspen Aerogels, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Arq, with an average 1-year price target of $9.0, suggesting a potential 922.73% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Rayonier Adv Materials, with an average 1-year price target of $11.0, suggesting a potential 1150.0% upside.</li>
<li>Analysts currently favor an Buy trajectory for Aspen Aerogels, with an average 1-year price target of $16.8, suggesting a potential 1809.09% upside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>The peer analysis summary offers a detailed examination of key metrics for Arq, Rayonier Adv Materials and Aspen Aerogels, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Alto Ingredients</td>
<td>Buy</td>
<td>-13.62%</td>
<td>$-1.39M</td>
<td>-17.19%</td>
</tr>
<tr>
<td>Arq</td>
<td>Buy</td>
<td>-3.79%</td>
<td>$9.80M</td>
<td>-0.62%</td>
</tr>
<tr>
<td>Rayonier Adv Materials</td>
<td>Outperform</td>
<td>0.00%</td>
<td>$36.94M</td>
<td>-2.24%</td>
</tr>
<tr>
<td>Aspen Aerogels</td>
<td>Buy</td>
<td>46.15%</td>
<td>$47.13M</td>
<td>2.02%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Alto Ingredients ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is also at the bottom for Return on Equity.</p>
<h3>Delving into Alto Ingredients's Background</h3>
<p>Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include major food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, Western production, and Others.</p>
<h3>Alto Ingredients: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Alto Ingredients's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately <strong>-13.62%</strong>. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.</p>
<p><strong>Net Margin:</strong> Alto Ingredients's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>-17.78%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Alto Ingredients's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of <strong>-17.19%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Return on Assets (ROA):</strong> Alto Ingredients's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-10.27%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.51</strong>, Alto Ingredients adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/ALTO/earnings"><strong>To track all earnings releases for Alto Ingredients visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Earnings

ALTO

Insights into Alto Ingredients's Upcoming Earnings

<p>RumbleON (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMBL#NASDAQ">RMBL</a>) is preparing to release its quarterly earnings on Wednesday, 2025-05-07. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect RumbleON to report an <strong>earnings per share</strong> (EPS) of $-0.23.</p>
<p>The market awaits RumbleON's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Performance in Previous Earnings</h3>
<p>In the previous earnings release, the company missed EPS by $1.35, leading to a 5.85% increase in the share price the following trading session.</p>
<p>Here's a look at RumbleON's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.23</td>
<td>-0.16</td>
<td>-0.09</td>
<td>-0.33</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-1.58</td>
<td>-0.32</td>
<td>-0.02</td>
<td>-0.29</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>6.0%</td>
<td>4.0%</td>
<td>3.0%</td>
<td>13.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554770_0.png" alt="eps graph" /></p>
<h3>Market Performance of RumbleON's Stock</h3>
<p>Shares of RumbleON were trading at $2.77 as of May 05. Over the last 52-week period, shares are down 50.92%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<h3>Analyst Insights on RumbleON</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on RumbleON.</p>
<p>With 4 analyst ratings, RumbleON has a consensus rating of Neutral. The average one-year price target is $4.25, indicating a potential 53.43% upside.</p>
<h3>Comparing Ratings Among Industry Peers</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of OneWater Marine and Monro, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for OneWater Marine, with an average 1-year price target of $16.75, suggesting a potential 504.69% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Monro, with an average 1-year price target of $18.8, suggesting a potential 578.7% upside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
<p>The peer analysis summary outlines pivotal metrics for OneWater Marine and Monro, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>RumbleON</td>
<td>Neutral</td>
<td>-13.37%</td>
<td>$67.50M</td>
<td>-94.00%</td>
</tr>
<tr>
<td>OneWater Marine</td>
<td>Neutral</td>
<td>-0.98%</td>
<td>$110.41M</td>
<td>-0.10%</td>
</tr>
<tr>
<td>Monro</td>
<td>Neutral</td>
<td>-3.74%</td>
<td>$104.80M</td>
<td>0.65%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>RumbleON is at the bottom for Revenue Growth and Gross Profit, with negative percentages. It is also at the bottom for Return on Equity, with a negative percentage.</p>
<h3>Get to Know RumbleON Better</h3>
<p>RumbleON Inc is a USA-based online retailer that allows both consumers and dealers to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience. Its segments include powersports dealership group and vehicle transportation services. The powersports dealership group segment is comprised of powersports dealerships that sell new and pre-owned powersports vehicles; parts, service and accessories; and finance and inventory products for powersports vehicles sold. The vehicle transportation services segment provides nationwide transportation brokerage services between dealerships and auctions.</p>
<h3>RumbleON's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Challenges:</strong> RumbleON's revenue growth over 3 months faced difficulties. As of 31 December, 2024, the company experienced a decline of approximately <strong>-13.37%</strong>. This indicates a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> RumbleON's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>-20.92%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> RumbleON's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>-94.0%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>-7.11%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> RumbleON's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>16.76</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<p><a href="https://www.benzinga.com/quote/RMBL/earnings"><strong>To track all earnings releases for RumbleON visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


RMBL

A Glimpse of RumbleON's Earnings Potential

<p>Myomo (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYO#AMEX">MYO</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-05-07. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Myomo will report an <strong>earnings per share</strong> (EPS) of $-0.08.</p>
<p>Anticipation surrounds Myomo's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company's EPS beat by $0.01 in the last quarter, leading to a 40.77% increase in the share price on the following day.</p>
<p>Here's a look at Myomo's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>-0.04</td>
<td>-0.09</td>
<td>-0.1</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.01</td>
<td>-0.03</td>
<td>-0.03</td>
<td>-0.1</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>41.0%</td>
<td>20.0%</td>
<td>-13.0%</td>
<td>-9.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554757_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Myomo were trading at $4.73 as of May 05. Over the last 52-week period, shares are up 18.83%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Insights Shared by Analysts on Myomo</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Myomo.</p>
<p>The consensus rating for Myomo is Buy, based on 3 analyst ratings. With an average one-year price target of $10.5, there's a potential 121.99% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of BrainsWay, LENSAR and Sight Sciences, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for BrainsWay, with an average 1-year price target of $16.0, suggesting a potential 238.27% upside.</li>
<li>Analysts currently favor an Buy trajectory for LENSAR, with an average 1-year price target of $15.5, suggesting a potential 227.7% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Sight Sciences, with an average 1-year price target of $3.6, suggesting a potential 23.89% downside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
<p>In the peer analysis summary, key metrics for BrainsWay, LENSAR and Sight Sciences are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Myomo</td>
<td>Buy</td>
<td>153.73%</td>
<td>$8.62M</td>
<td>-1.53%</td>
</tr>
<tr>
<td>BrainsWay</td>
<td>Buy</td>
<td>26.41%</td>
<td>$8.51M</td>
<td>2.91%</td>
</tr>
<tr>
<td>LENSAR</td>
<td>Buy</td>
<td>38.22%</td>
<td>$7.11M</td>
<td>-135.52%</td>
</tr>
<tr>
<td>Sight Sciences</td>
<td>Neutral</td>
<td>1.72%</td>
<td>$16.56M</td>
<td>-12.98%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Myomo ranks first in revenue growth among its peers. It has the highest gross profit margin. However, it has the lowest return on equity.</p>
<h3>All You Need to Know About Myomo</h3>
<p>Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).</p>
<h3>Myomo's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> Myomo displayed positive results in 3 months. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately <strong>153.73%</strong>. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>-2.15%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Myomo's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>-1.53%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Myomo's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>-0.89%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Myomo's debt-to-equity ratio is below the industry average. With a ratio of <b>0.33</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<p><a href="https://www.benzinga.com/quote/MYO/earnings"><strong>To track all earnings releases for Myomo visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


A Glimpse of Myomo's Earnings Potential

<p>Piedmont Lithium (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLL#NASDAQ">PLL</a>) will release its quarterly earnings report on Wednesday, 2025-05-07. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Piedmont Lithium to report an <strong>earnings per share</strong> (EPS) of $-0.58.</p>
<p>Anticipation surrounds Piedmont Lithium's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings Track Record</h3>
<p>During the last quarter, the company reported an EPS beat by $0.36, leading to a 4.12% drop in the share price on the subsequent day.</p>
<p>Here's a look at Piedmont Lithium's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.53</td>
<td>-0.57</td>
<td>-0.33</td>
<td>-0.37</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.17</td>
<td>-0.42</td>
<td>-0.65</td>
<td>-0.61</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-4.0%</td>
<td>3.0%</td>
<td>-6.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554745_0.png" alt="eps graph" /></p>
<h3>Tracking Piedmont Lithium's Stock Performance</h3>
<p>Shares of Piedmont Lithium were trading at $7.27 as of May 05. Over the last 52-week period, shares are down 43.33%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/PLL/earnings"><strong>To track all earnings releases for Piedmont Lithium visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Uncovering Potential: Piedmont Lithium's Earnings Preview

<p>Matrix Service (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTRX#NASDAQ">MTRX</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-05-07. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that Matrix Service will report an <strong>earnings per share</strong> (EPS) of $-0.05.</p>
<p>Anticipation surrounds Matrix Service's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.</p>
<p>New investors should understand that while earnings performance is important, market reactions are often driven by guidance.</p>
<h3>Earnings History Snapshot</h3>
<p>In the previous earnings release, the company beat EPS by $0.02, leading to a 0.71% increase in the share price the following trading session.</p>

<p><img src="https://www.benzinga.com/files/images/story/2025/1746554710_0.png" alt="eps graph" /></p>
<h3>Performance of Matrix Service Shares</h3>
<p>Shares of Matrix Service were trading at $12.07 as of May 05. Over the last 52-week period, shares are up 2.03%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/MTRX/earnings"><strong>To track all earnings releases for Matrix Service visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MTRX

A Peek at Matrix Service's Future Earnings

<p>BGSF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BGSF#NYSE">BGSF</a>) will release its quarterly earnings report on Wednesday, 2025-05-07. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate BGSF to report an <strong>earnings per share</strong> (EPS) of $-0.11.</p>
<p>BGSF bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.</p>
<p>New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).</p>
<h3>Earnings History Snapshot</h3>
<p>During the last quarter, the company reported an EPS beat by $0.02, leading to a 8.76% drop in the share price on the subsequent day.</p>
<p>Here's a look at BGSF's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.08</td>
<td>0.11</td>
<td>0.08</td>
<td>-0.04</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.06</td>
<td>0.10</td>
<td>0.07</td>
<td>0.07</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-9.0%</td>
<td>-5.0%</td>
<td>-1.0%</td>
<td>-16.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554683_0.png" alt="eps graph" /></p>
<h3>Tracking BGSF's Stock Performance</h3>
<p>Shares of BGSF were trading at $3.31 as of May 05. Over the last 52-week period, shares are down 62.54%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. </p>
<h3>Analysts' Perspectives on BGSF</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on BGSF.</p>
<p>BGSF has received a total of 1 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $9.0, the consensus suggests a potential 171.9% upside.</p>
<h3>Peer Ratings Comparison</h3>
<p>In this comparison, we explore the analyst ratings and average 1-year price targets of Asure Software, Kelly Services and Kforce, three prominent industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Outperform trajectory for Asure Software, with an average 1-year price target of $17.71, suggesting a potential 435.05% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Kelly Services, with an average 1-year price target of $25.0, suggesting a potential 655.29% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Kforce, with an average 1-year price target of $45.0, suggesting a potential 1259.52% upside.</li>
</ul>
<h3>Peers Comparative Analysis Summary</h3>
<p>The peer analysis summary outlines pivotal metrics for Asure Software, Kelly Services and Kforce, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>BGSF</td>
<td>Buy</td>
<td>-12.45%</td>
<td>$21.47M</td>
<td>-1.19%</td>
</tr>
<tr>
<td>Asure Software</td>
<td>Outperform</td>
<td>10.12%</td>
<td>$24.61M</td>
<td>-1.21%</td>
</tr>
<tr>
<td>Kelly Services</td>
<td>Outperform</td>
<td>-3.34%</td>
<td>$241.50M</td>
<td>-2.46%</td>
</tr>
<tr>
<td>Kforce</td>
<td>Neutral</td>
<td>-6.21%</td>
<td>$88.26M</td>
<td>5.57%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>BGSF ranks at the bottom for Revenue Growth and Gross Profit among its peers. It is also at the bottom for Return on Equity. Overall, BGSF's performance is weaker compared to its peers in terms of financial metrics.</p>
<h3>Unveiling the Story Behind BGSF</h3>
<p>BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.</p>
<h3>Understanding the Numbers: BGSF's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Decline in Revenue:</strong> Over the 3 months period, BGSF faced challenges, resulting in a decline of approximately <strong>-12.45%</strong> in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>-1.52%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> BGSF's ROE excels beyond industry benchmarks, reaching <strong>-1.19%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> BGSF's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of <strong>-0.64%,</strong> the company showcases efficient use of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>0.63</strong>, BGSF adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/BGSF/earnings"><strong>To track all earnings releases for BGSF visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


BGSF

A Peek at BGSF's Future Earnings

<p><a href="https://www.theinformation.com/articles/amazon-shopify-lenders-tighten-trade-risks-mount">https://www.theinformation.com/articles/amazon-shopify-lenders-tighten-trade-risks-mount</a></p>


AMZN

SHOP

'Amazon, Shopify Lenders Tighten Up As Trade Risks Mount'- The Information

<p>Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) is preparing to release its quarterly earnings on Wednesday, 2025-05-07. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Ares Comml Real Est to report an <strong>earnings per share</strong> (EPS) of $0.08.</p>
<p>The announcement from Ares Comml Real Est is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Earnings Track Record</h3>
<p>In the previous earnings release, the company missed EPS by $0.17, leading to a 5.05% drop in the share price the following trading session.</p>
<p>Here's a look at Ares Comml Real Est's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0.02</td>
<td>0.04</td>
<td>0.12</td>
<td>-0.15</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.15</td>
<td>0.07</td>
<td>-0.12</td>
<td>-0.62</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-5.0%</td>
<td>1.0%</td>
<td>2.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554638_0.png" alt="eps graph" /></p>
<h3>Stock Performance</h3>
<p>Shares of Ares Comml Real Est were trading at $4.17 as of May 05. Over the last 52-week period, shares are down 40.35%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/ACRE/earnings"><strong>To track all earnings releases for Ares Comml Real Est visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


ACRE

Insights into Ares Comml Real Est's Upcoming Earnings

<p>Arq (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARQ#NASDAQ">ARQ</a>) will release its quarterly earnings report on Wednesday, 2025-05-07. Here's a brief overview for investors ahead of the announcement.</p>
<p>Analysts anticipate Arq to report an <strong>earnings per share</strong> (EPS) of $-0.02.</p>
<p>Investors in Arq are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.</p>
<p>It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.</p>
<h3>Performance in Previous Earnings</h3>
<p>The company's EPS missed by $0.01 in the last quarter, leading to a 5.86% drop in the share price on the following day.</p>
<p>Here's a look at Arq's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>-0.02</td>
<td>0.03</td>
<td></td>
<td>-0.07</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>-0.03</td>
<td>0.04</td>
<td>-0.06</td>
<td>-0.09</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>-6.0%</td>
<td>3.0%</td>
<td>5.0%</td>
<td>-5.0%</td>
</tr>
</tbody>
</table>
</p>
<h3>Tracking Arq's Stock Performance</h3>
<p>Shares of Arq were trading at $4.12 as of May 05. Over the last 52-week period, shares are down 47.38%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. </p>
<h3>Analyst Opinions on Arq</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Arq.</p>
<p>The consensus rating for Arq is Buy, derived from 1 analyst ratings. An average one-year price target of $9.0 implies a potential 118.45% upside.</p>
<h3>Understanding Analyst Ratings Among Peers</h3>
<p>The following analysis focuses on the analyst ratings and average 1-year price targets of Alto Ingredients, Rayonier Adv Materials and Aspen Aerogels, three prominent industry players, providing insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for Alto Ingredients, with an average 1-year price target of $5.5, suggesting a potential 33.5% upside.</li>
<li>Analysts currently favor an Outperform trajectory for Rayonier Adv Materials, with an average 1-year price target of $11.0, suggesting a potential 166.99% upside.</li>
<li>Analysts currently favor an Buy trajectory for Aspen Aerogels, with an average 1-year price target of $16.8, suggesting a potential 307.77% upside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
<p>The peer analysis summary provides a snapshot of key metrics for Alto Ingredients, Rayonier Adv Materials and Aspen Aerogels, illuminating their respective standings within the industry. These metrics offer valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Arq</td>
<td>Buy</td>
<td>-3.79%</td>
<td>$9.80M</td>
<td>-0.62%</td>
</tr>
<tr>
<td>Alto Ingredients</td>
<td>Buy</td>
<td>-13.62%</td>
<td>$-1.39M</td>
<td>-17.19%</td>
</tr>
<tr>
<td>Rayonier Adv Materials</td>
<td>Outperform</td>
<td>0.00%</td>
<td>$36.94M</td>
<td>-2.24%</td>
</tr>
<tr>
<td>Aspen Aerogels</td>
<td>Buy</td>
<td>46.15%</td>
<td>$47.13M</td>
<td>2.02%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Arq is at the bottom for Revenue Growth and Gross Profit, with negative values for both metrics. It is also at the bottom for Return on Equity, with a negative value. Overall, Arq is performing poorly compared to its peers in terms of financial metrics.</p>
<h3>About Arq</h3>
<p>Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granula Activated Carbon, and Colloidal Carbon Product among others.</p>
<h3>Breaking Down Arq's Financial Performance</h3>
<p><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p>
<p><strong>Revenue Growth:</strong> Arq's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately <strong>-3.79%</strong>. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.</p>
<p><strong>Net Margin:</strong> Arq's net margin is impressive, surpassing industry averages. With a net margin of <strong>-4.95%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Arq's ROE excels beyond industry benchmarks, reaching <strong>-0.62%</strong>. This signifies robust financial management and efficient use of shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Arq's ROA excels beyond industry benchmarks, reaching <strong>-0.47%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Arq's debt-to-equity ratio is below the industry average at <strong>0.16</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<p><a href="https://www.benzinga.com/quote/ARQ/earnings"><strong>To track all earnings releases for Arq visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


An Overview of Arq's Earnings

<p><strong>DHI Group</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHX#NYSE">DHX</a>) is set to give its latest quarterly earnings report on Wednesday, 2025-05-07. Here's what investors need to know before the announcement.</p>
<p>Analysts estimate that DHI Group will report an <strong>earnings per share</strong> (EPS) of $0.00. </p>
<p>The announcement from DHI Group is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p>
<p>It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p>
<h3>Overview of Past Earnings</h3>
<p>The company's EPS beat by $0.07 in the last quarter, leading to a 7.53% increase in the share price on the following day.</p>
<p>Here's a look at DHI Group's past performance and the resulting price change:</p>
<p>
<table>
<thead>
<tr>
<th><strong>Quarter</strong></th>
<th><strong>Q4 2024</strong></th>
<th><strong>Q3 2024</strong></th>
<th><strong>Q2 2024</strong></th>
<th><strong>Q1 2024</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>EPS Estimate</strong></td>
<td>0</td>
<td>0.03</td>
<td>0.03</td>
<td>0.02</td>
</tr>
<tr>
<td><strong>EPS Actual</strong></td>
<td>0.07</td>
<td>0.05</td>
<td>0.06</td>
<td>0.05</td>
</tr>
<tr>
<td><strong>Price Change %</strong></td>
<td>8.0%</td>
<td>-7.000000000000001%</td>
<td>17.0%</td>
<td>-10.0%</td>
</tr>
</tbody>
</table>
</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554615_0.png" alt="eps graph" /></p>
<h3>Market Performance of DHI Group's Stock</h3>
<p>Shares of DHI Group were trading at $1.33 as of May 05. Over the last 52-week period, shares are down 53.45%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<h3>Analyst Observations about DHI Group</h3>
<p>For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on DHI Group.</p>
<p>Analysts have provided DHI Group with 3 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $7.0, suggesting a potential 426.32% upside.</p>
<h3>Analyzing Analyst Ratings Among Peers</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of PSQ Holdings and Giftify, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Buy trajectory for PSQ Holdings, with an average 1-year price target of $4.0, suggesting a potential 200.75% upside.</li>
<li>Analysts currently favor an Buy trajectory for Giftify, with an average 1-year price target of $4.0, suggesting a potential 200.75% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
<p>In the peer analysis summary, key metrics for PSQ Holdings and Giftify are highlighted, providing an understanding of their respective standings within the industry and offering insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>DHI Group</td>
<td>Outperform</td>
<td>-6.71%</td>
<td>$29.70M</td>
<td>0.91%</td>
</tr>
<tr>
<td>PSQ Holdings</td>
<td>Buy</td>
<td>162.37%</td>
<td>$4.42M</td>
<td>-132.71%</td>
</tr>
<tr>
<td>Giftify</td>
<td>Buy</td>
<td>14.05%</td>
<td>$3.64M</td>
<td>-17.88%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>DHI Group is at the bottom for Revenue Growth and Gross Profit, while it is in the middle for Return on Equity.</p>
<h3>All You Need to Know About DHI Group</h3>
<p>DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.</p>
<h3>DHI Group: Delving into Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Revenue Growth:</strong> DHI Group's revenue growth over a period of 3 months has faced challenges. As of 31 December, 2024, the company experienced a revenue decline of approximately <strong>-6.71%</strong>. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Communication Services sector.</p>
<p><strong>Net Margin:</strong> DHI Group's net margin excels beyond industry benchmarks, reaching <strong>2.94%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> DHI Group's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>0.91%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> DHI Group's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>0.46%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at <strong>0.37</strong>.</p>
<p><a href="https://www.benzinga.com/quote/DHX/earnings"><strong>To track all earnings releases for DHI Group visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


Examining the Future: DHI Group's Earnings Outlook

<p>Aris Water Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>) is preparing to release its quarterly earnings on Tuesday, 2025-05-06. Here's a brief overview of what investors should keep in mind before the announcement.</p>
<p>Analysts expect Aris Water Solutions to report an <strong>earnings per share</strong> (EPS) of $0.28.</p>
<p>The market awaits Aris Water Solutions's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Overview of Past Earnings</h3>
<p>During the last quarter, the company reported an EPS missed by $0.07, leading to a 20.73% increase in the share price on the subsequent day.</p>

<h3>Stock Performance</h3>
<p>Shares of Aris Water Solutions were trading at $25.52 as of May 05. Over the last 52-week period, shares are up 49.33%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. </p>
<h3>Analyst Opinions on Aris Water Solutions</h3>
<p>Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on Aris Water Solutions.</p>
<p>Analysts have provided Aris Water Solutions with 1 ratings, resulting in a consensus rating of Neutral. The average one-year price target stands at $29.0, suggesting a potential 13.64% upside.</p>
<h3>Comparing Ratings with Competitors</h3>
<p>In this analysis, we delve into the analyst ratings and average 1-year price targets of ProFrac Holding, Solaris Energy and NPK International, three key industry players, offering insights into their relative performance expectations and market positioning.</p>
<ul>
<li>Analysts currently favor an Neutral trajectory for ProFrac Holding, with an average 1-year price target of $6.5, suggesting a potential 74.53% downside.</li>
<li>Analysts currently favor an Outperform trajectory for Solaris Energy, with an average 1-year price target of $48.6, suggesting a potential 90.44% upside.</li>
<li>Analysts currently favor an Buy trajectory for NPK International, with an average 1-year price target of $12.0, suggesting a potential 52.98% downside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
<p>The peer analysis summary outlines pivotal metrics for ProFrac Holding, Solaris Energy and NPK International, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.</p>
<p>
<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Aris Water Solutions</td>
<td>Neutral</td>
<td>13.91%</td>
<td>$46.55M</td>
<td>1.10%</td>
</tr>
<tr>
<td>ProFrac Holding</td>
<td>Neutral</td>
<td>-7.03%</td>
<td>$3.80M</td>
<td>-9.96%</td>
</tr>
<tr>
<td>Solaris Energy</td>
<td>Outperform</td>
<td>31.19%</td>
<td>$27.59M</td>
<td>1.41%</td>
</tr>
<tr>
<td>NPK International</td>
<td>Buy</td>
<td>32.29%</td>
<td>$25.25M</td>
<td>3.06%</td>
</tr>
</tbody>
</table>
</p>
<p>Key Takeaway:</p>
<p>Aris Water Solutions ranks in the middle for consensus rating. It is at the bottom for revenue growth among peers. In terms of gross profit, it is at the top. For return on equity, it is in the middle compared to its peers.</p>
<h3>Discovering Aris Water Solutions: A Closer Look</h3>
<p>Aris Water Solutions Inc is an environmental infrastructure and solutions company delivering full-cycle water handling and recycling solutions. Its integrated pipelines and related infrastructure create long-term value by delivering high-capacity, comprehensive produced water management, recycling, and supply solutions to operators in the core areas of the Permian Basin. The company manages its business through a single operating segment comprising two primary revenue streams, Produced Water Handling and Water Solutions. The Produced Water Handling business gathers, transports, and unless recycled, handles produced water generated from oil and natural gas production, and the Water Solutions business develops and operates recycling facilities to treat, store, and recycle produced water.</p>
<h3>Financial Insights: Aris Water Solutions</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Aris Water Solutions's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of <strong>13.91%</strong>. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Energy sector.</p>
<p><strong>Net Margin:</strong> Aris Water Solutions's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>3.2%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Aris Water Solutions's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>1.1%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>0.27%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> With a below-average debt-to-equity ratio of <strong>1.32</strong>, Aris Water Solutions adopts a prudent financial strategy, indicating a balanced approach to debt management.</p>
<p><a href="https://www.benzinga.com/quote/ARIS/earnings"><strong>To track all earnings releases for Aris Water Solutions visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


ARIS

Earnings Outlook For Aris Water Solutions

<p>SandRidge Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SD#NYSE">SD</a>) is gearing up to announce its quarterly earnings on Wednesday, 2025-05-07. Here's a quick overview of what investors should know before the release.</p>
<p>Analysts are estimating that SandRidge Energy will report an <strong>earnings per share</strong> (EPS) of $0.43.</p>
<p>The market awaits SandRidge Energy's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.</p>
<p>It's important for new investors to understand that guidance can be a significant driver of stock prices.</p>
<h3>Past Earnings Performance</h3>
<p>During the last quarter, the company reported an EPS missed by $0.20, leading to a 2.76% drop in the share price on the subsequent day.</p>

<h3>Tracking SandRidge Energy's Stock Performance</h3>
<p>Shares of SandRidge Energy were trading at $9.15 as of May 05. Over the last 52-week period, shares are down 30.96%.  Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. </p>
<p><a href="https://www.benzinga.com/quote/SD/earnings"><strong>To track all earnings releases for SandRidge Energy visit their earnings calendar on our site.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


SandRidge Energy's Earnings Outlook

<p>Financial giants have made a conspicuous bullish move on Tesla. Our analysis of options history for Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) revealed 373 unusual trades.</p>
<p>Delving into the details, we found 45% of traders were bullish, while 42% showed bearish tendencies. Out of all the trades we spotted, 220 were puts, with a value of $14,986,528, and 153 were calls, valued at $9,386,580.</p>
<h3>Expected Price Movements</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $175.0 to $790.0 for Tesla over the recent three months. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Tesla's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Tesla's substantial trades, within a strike price spectrum from $175.0 to $790.0 over the preceding 30 days.</p>
<h3>Tesla Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554490_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$126.95</td>
<td>$126.1</td>
<td>$126.58</td>
<td>$400.00</td>
<td>$379.6K</td>
<td>6.9K</td>
<td>237</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$65.95</td>
<td>$65.85</td>
<td>$65.85</td>
<td>$280.00</td>
<td>$237.0K</td>
<td>2.9K</td>
<td>67</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/09/25</td>
<td>$5.8</td>
<td>$5.75</td>
<td>$5.8</td>
<td>$270.00</td>
<td>$142.0K</td>
<td>14.6K</td>
<td>57.1K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/09/25</td>
<td>$9.2</td>
<td>$9.1</td>
<td>$9.13</td>
<td>$270.00</td>
<td>$139.1K</td>
<td>3.4K</td>
<td>9.6K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/09/25</td>
<td>$5.05</td>
<td>$5.0</td>
<td>$5.0</td>
<td>$280.00</td>
<td>$109.5K</td>
<td>12.2K</td>
<td>41.8K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Tesla</h3>
<p>Tesla is a vertically integrated battery electric vehicle automaker and developer of autonomous driving software. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling more affordable vehicles, a sports car, and offer a robotaxi service. Global deliveries in 2024 were a little below 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network.</p>
<p>After a thorough review of the options trading surrounding Tesla, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Where Is Tesla Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 54,574,133, the TSLA's price is down by -2.56%, now at $273.09. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 77 days.</li>
</ul>
<h3>What The Experts Say On Tesla</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $236.21.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Wedbush keeps a Outperform rating on Tesla with a target price of $315.<br />
&#x2A; An analyst from UBS persists with their Sell rating on Tesla, maintaining a target price of $190.<br />
&#x2A; An analyst from Benchmark has decided to maintain their Buy rating on Tesla, which currently sits at a price target of $350.<br />
&#x2A; Consistent in their evaluation, an analyst from GLJ Research keeps a Sell rating on Tesla with a target price of $19.<br />
&#x2A; An analyst from RBC Capital persists with their Outperform rating on Tesla, maintaining a target price of $307. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Tesla, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Options

Markets

TSLA

Behind the Scenes of Tesla's Latest Options Trends

<p>Investors with a lot of money to spend have taken a bullish stance on <strong>NIO</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with NIO, it often means somebody knows something is about to happen.</p>
<p>Today, Benzinga's options scanner spotted 8 options trades for <strong>NIO</strong>.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 75% bullish and 0%, bearish.</p>
<p>Out of all of the options we uncovered, there was 1 put, for a total amount of $32,568, and 7, calls, for a total amount of $492,293.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $3.0 to $5.5 for NIO over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in NIO's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to NIO's substantial trades, within a strike price spectrum from $3.0 to $5.5 over the preceding 30 days.</p>
<h3>NIO Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554484_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$0.57</td>
<td>$0.56</td>
<td>$0.57</td>
<td>$5.00</td>
<td>$144.9K</td>
<td>107.9K</td>
<td>5.1K</td>
</tr>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$0.57</td>
<td>$0.56</td>
<td>$0.57</td>
<td>$5.00</td>
<td>$136.1K</td>
<td>107.9K</td>
<td>2.4K</td>
</tr>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$0.96</td>
<td>$0.94</td>
<td>$0.95</td>
<td>$3.00</td>
<td>$94.2K</td>
<td>4.2K</td>
<td>1.1K</td>
</tr>
<tr>
<td>NIO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$0.84</td>
<td>$0.83</td>
<td>$0.84</td>
<td>$4.00</td>
<td>$33.6K</td>
<td>49.2K</td>
<td>784</td>
</tr>
<tr>
<td>NIO</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$1.8</td>
<td>$1.77</td>
<td>$1.77</td>
<td>$5.50</td>
<td>$32.5K</td>
<td>576</td>
<td>184</td>
</tr>
</tbody>
</table>
</p>
<h3>About NIO</h3>
<p>Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.</p>
<p>Following our analysis of the options activities associated with NIO, we pivot to a closer look at the company's own performance.</p>
<h3>Present Market Standing of NIO</h3>
<ul>
<li>With a trading volume of 23,831,040, the price of NIO is down by -1.76%, reaching $3.91.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 30 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for NIO</h3>
<p>A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $3.5.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Neutral rating on NIO with a target price of $3. </p>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for NIO with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.</p>


NIO's Options Frenzy: What You Need to Know

<p>High-rolling investors have positioned themselves bullish on Cenovus Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVE#NYSE">CVE</a>), and it's important for retail traders to take note.<br />
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in CVE often signals that someone has privileged information.</p>
<p>Today, Benzinga's options scanner spotted 10 options trades for Cenovus Energy. This is not a typical pattern.</p>
<p>The sentiment among these major traders is split, with 50% bullish and 50% bearish. Among all the options we identified, there was one put, amounting to $58,720, and 9 calls, totaling $1,063,861.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $11.0 to $15.0 for Cenovus Energy over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Cenovus Energy stands at 5051.17, with a total volume reaching 17,955.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Cenovus Energy, situated within the strike price corridor from $11.0 to $15.0, throughout the last 30 days.</p>
<h3>Cenovus Energy 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554479_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CVE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$0.7</td>
<td>$0.6</td>
<td>$0.6</td>
<td>$15.00</td>
<td>$300.5K</td>
<td>23.0K</td>
<td>5.0K</td>
</tr>
<tr>
<td>CVE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$1.25</td>
<td>$1.15</td>
<td>$1.15</td>
<td>$13.00</td>
<td>$251.8K</td>
<td>0</td>
<td>3.5K</td>
</tr>
<tr>
<td>CVE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$1.2</td>
<td>$1.05</td>
<td>$1.05</td>
<td>$13.00</td>
<td>$105.1K</td>
<td>0</td>
<td>1.0K</td>
</tr>
<tr>
<td>CVE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$1.25</td>
<td>$1.15</td>
<td>$1.25</td>
<td>$12.00</td>
<td>$103.7K</td>
<td>310</td>
<td>1.0K</td>
</tr>
<tr>
<td>CVE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$1.2</td>
<td>$1.15</td>
<td>$1.2</td>
<td>$12.00</td>
<td>$86.6K</td>
<td>310</td>
<td>932</td>
</tr>
</tbody>
</table>
</p>
<h3>About Cenovus Energy</h3>
<p>Cenovus Energy Inc is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 786 thousand barrels of oil equivalent per day in 2022. The company had upstream projects across Western Canada; crude oil production and natural gas and NGLs production offshore China and Indonesia. The downstream operations include upgrading and refining operations in Canada and the U.S., and commercial fuel operations across Canada.</p>
<h3>Where Is Cenovus Energy Standing Right Now?</h3>
<ul>
<li>With a volume of 8,666,698, the price of CVE is up 1.2% at $11.8. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 2 days.</li>
</ul>
<h3>What The Experts Say On Cenovus Energy</h3>
<p>Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $20.5.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from RBC Capital has revised its rating downward to Outperform, adjusting the price target to $25.<br />
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on Cenovus Energy, which currently sits at a price target of $16. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Cenovus Energy, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


Spotlight on Cenovus Energy: Analyzing the Surge in Options Activity

<p>Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) in the last three months.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $100.17, a high estimate of $141.00, and a low estimate of $40.00. Witnessing a positive shift, the current average has risen by 2.12% from the previous average price target of $98.09.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554454_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>The standing of Palantir Technologies among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gabriela Borges</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$90.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Sanjit Singh</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$98.00</td>
<td>$90.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$110.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Thomas Blakey</td>
<td>Cantor Fitzgerald</td>
<td>Raises</td>
<td>Neutral</td>
<td>$110.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Matthew Broome</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Underperform</td>
<td>$94.00</td>
<td>$80.00</td>
</tr>
<tr>
<td>Rishi Jaluria</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Underperform</td>
<td>$40.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Sanjit Singh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$90.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$100.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Mark Schappel</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$125.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Louie DiPalma</td>
<td>William Blair</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$84.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Daniel Ives</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$120.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Mark Schappel</td>
<td>Loop Capital</td>
<td>Announces</td>
<td>Buy</td>
<td>$141.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Palantir Technologies. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Palantir Technologies compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Capture valuable insights into Palantir Technologies's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/PLTR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Palantir Technologies analyst ratings.</strong></a></p>
<h2>Get to Know Palantir Technologies Better</h2>
<p>Palantir is an analytical software company that focuses on leveraging data to create efficiencies in its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. Palantir works only with entities in Western-allied nations and reserves the right not to work with anyone that is antithetical to Western values. The Denver-based company was founded in 2003 and went public in 2020.</p>
<h3>Understanding the Numbers: Palantir Technologies's Finances</h3>
<p><strong>Market Capitalization:</strong> Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.</p>
<p><strong>Revenue Growth:</strong> Palantir Technologies displayed positive results in 3M. As of 31 December, 2024, the company achieved a solid revenue growth rate of approximately <strong>36.03%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> Palantir Technologies's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>9.55%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Palantir Technologies's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>1.66%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Palantir Technologies's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of <strong>1.31%,</strong> the company may face hurdles in generating optimal returns from its assets.</p>
<p><strong>Debt Management:</strong> Palantir Technologies's debt-to-equity ratio is below the industry average. With a ratio of <b>0.05</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

PLTR

What 12 Analyst Ratings Have To Say About Palantir Technologies

<p>Providing a diverse range of perspectives from bullish to bearish, 16 analysts have published ratings on Olin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLN#NYSE">OLN</a>) in the last three months.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">14</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Olin and provided 12-month price targets. The average target is $25.44, accompanied by a high estimate of $34.00 and a low estimate of $19.00. A decline of 19.87% from the prior average price target is evident in the current average. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554446_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>A clear picture of Olin's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Duffy Fischer</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$25.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$20.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$22.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$24.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Arun Viswanathan</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Aleksey Yefremov</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$34.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Peter Osterland</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$25.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$19.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Joshua Spector</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$21.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$26.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Michael Sison</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$25.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Michael Leithead</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$28.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Patrick Cunningham</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Jeffrey Zekauskas</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$28.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Charles Neivert</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$33.00</td>
<td>$41.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Olin. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Olin compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Olin's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>To gain a panoramic view of Olin's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/OLN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Olin analyst ratings.</strong></a></p>
<h2>Delving into Olin's Background</h2>
<p>Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.</p>
<h3>Key Indicators: Olin's Financial Health</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Olin's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>0.54%</strong> as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>0.07%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Olin's ROE stands out, surpassing industry averages. With an impressive ROE of <strong>0.06%</strong>, the company demonstrates effective use of equity capital and strong financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Olin's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>0.02%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Olin's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>1.66</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


16 Analysts Assess Olin: What You Need To Know

<p>In the current market session, <strong>Amer Sports Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AS#NYSE">AS</a>)</strong> stock price is at $25.60, after a <strong>0.47%</strong> drop. However, over the past month, the company's stock increased by <strong>22.22%</strong>, and in the past year, by <strong>84.39%</strong>. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1746554442_0.png" alt="Past Year Chart" /></p>

<h3>How Does Amer Sports P/E Compare to Other Companies?</h3>
<p>The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. </p>
<p>Amer Sports has a better P/E ratio of <strong>183.71</strong> than the aggregate P/E ratio of <strong>30.1</strong> of the Textiles, Apparel &amp; Luxury Goods industry. Ideally, one might believe that Amer Sports Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. </p>
<p>
</p><p><img src="https://www.benzinga.com/files/images/story/2025/1746554442_1.png" alt="Guage" /></p>

<p>In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions. </p>


Intraday Update

P/E Ratio Insights for Amer Sports

<p>Ratings for Labcorp Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>) were provided by 10 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Labcorp Hldgs and provided 12-month price targets. The average target is $269.7, accompanied by a high estimate of $300.00 and a low estimate of $240.00. Observing a 4.0% increase, the current average has risen from the previous average price target of $259.33. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1746554439_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The standing of Labcorp Hldgs among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>David Westenberg</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$280.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Jack Meehan</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$250.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Eric Coldwell</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$267.00</td>
<td>$253.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$274.00</td>
<td>$285.00</td>
</tr>
<tr>
<td>Jack Meehan</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$240.00</td>
<td>$260.00</td>
</tr>
<tr>
<td>Jamie Clark</td>
<td>Redburn Atlantic</td>
<td>Announces</td>
<td>Buy</td>
<td>$276.00</td>
<td>-</td>
</tr>
<tr>
<td>Ralph Giacobbe</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$300.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>David Westenberg</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$260.00</td>
<td>$240.00</td>
</tr>
<tr>
<td>Jack Meehan</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$260.00</td>
<td>$271.00</td>
</tr>
<tr>
<td>Tycho Peterson</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$290.00</td>
<td>$275.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Labcorp Hldgs. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Labcorp Hldgs compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for Labcorp Hldgs's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>To gain a panoramic view of Labcorp Hldgs's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/LH/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Labcorp Hldgs analyst ratings.</strong></a></p>
<h2>Delving into Labcorp Hldgs's Background</h2>
<p>Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.</p>
<h3>Understanding the Numbers: Labcorp Hldgs's Finances</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.</p>
<p><strong>Revenue Growth:</strong> Labcorp Hldgs's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately <strong>5.3%</strong>. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Health Care sector.</p>
<p><strong>Net Margin:</strong> Labcorp Hldgs's net margin is impressive, surpassing industry averages. With a net margin of <strong>6.36%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Labcorp Hldgs's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of <strong>2.6%,</strong> the company may encounter challenges in delivering satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> Labcorp Hldgs's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>1.18%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p>
<p><strong>Debt Management:</strong> Labcorp Hldgs's debt-to-equity ratio is below the industry average. With a ratio of <b>0.78</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Laboratory Corporation Of America Holdings

Comments

Evonik Indus

Vendite allo scoperto

Evonik Indus (OTC:EVKIY) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO